Literature DB >> 27983990

Selective disulfide reduction for labeling and enhancement of Fab antibody fragments.

Terence L Kirley1, Kenneth D Greis2, Andrew B Norman3.   

Abstract

Many methods have been developed for chemical labeling and enhancement of the properties of antibodies and their common fragments, including the Fab and F(ab')2 fragments. Somewhat selective reduction of some antibody disulfide bonds has been previously achieved, yielding antibodies and antibody fragments that can be labeled at defined sites, enhancing their utility and properties. Selective reduction of the two hinge disulfide bonds present in F(ab')2 fragments using mild reduction has been useful. However, such reduction is often not quantitative and results in the reduction of multiple disulfide bonds, and therefore subsequent multiple labeling or conjugation sites are neither homogenous nor stoichiometric. Here, a simple and efficient selective reduction of the single disulfide bond linking the partial heavy chain and the intact light chain which compose the Fab fragment is accomplished utilizing tris(2-carboxyethyl)phosphine (TCEP) immobilized on agarose beads. The resultant reduced cysteine residues were labeled with several cysteine-selective fluorescent reagents, as well as by cysteine-directed PEGylation. These two cysteine residues can also be re-ligated by means of a bifunctional cysteine cross-linking agent, dibromobimane, thereby both restoring a covalent linkage between the heavy and light chains at this site, far removed from the antigen binding site, and also introducing a fluorescent probe. There are many other research and clinical uses for these selectively partially reduced Fab fragments, including biotinylation, toxin and drug conjugation, and incorporation of radioisotopes, and this technique enables simple generation of very useful Fab fragment derivatives with many potential applications.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody conjugation; Fab fragments; Monoclonal antibody; Selective disulfide reduction; Sulfhydryl modification; TCEP agarose

Mesh:

Substances:

Year:  2016        PMID: 27983990      PMCID: PMC5362313          DOI: 10.1016/j.bbrc.2016.10.128

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Characterization of IgG1 immunoglobulins and peptide-Fc fusion proteins by limited proteolysis in conjunction with LC-MS.

Authors:  Gerd R Kleemann; Jill Beierle; Andrew C Nichols; Thomas M Dillon; Gary D Pipes; Pavel V Bondarenko
Journal:  Anal Chem       Date:  2008-02-23       Impact factor: 6.986

2.  A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization.

Authors:  Yan An; Ying Zhang; Hans-Martin Mueller; Mohammed Shameem; Xiaoyu Chen
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

3.  Influence of molecular design on biodistribution and targeting properties of an Affibody-fused HER2-recognising anticancer toxin.

Authors:  Mohamed Altai; Hao Liu; Anna Orlova; Vladimir Tolmachev; Torbjörn Gräslund
Journal:  Int J Oncol       Date:  2016-07-06       Impact factor: 5.650

4.  Conjugation of glucose oxidase from Aspergillus niger and rabbit antibodies using N-hydroxysuccinimide ester of N-(4-carboxycyclohexylmethyl)-maleimide.

Authors:  S Yoshitake; Y Yamada; E Ishikawa; R Masseyeff
Journal:  Eur J Biochem       Date:  1979-11

5.  Preparation, characterization, and in vivo biodistribution properties of synthetically cross-linked multivalent antitumor antibody fragments.

Authors:  M E Schott; K A Frazier; D K Pollock; K M Verbanac
Journal:  Bioconjug Chem       Date:  1993 Mar-Apr       Impact factor: 4.774

6.  Structural characterization of expressed monoclonal antibodies by single sample mass spectral analysis after IdeS proteolysis.

Authors:  Terence L Kirley; Kenneth D Greis; Andrew B Norman
Journal:  Biochem Biophys Res Commun       Date:  2016-06-21       Impact factor: 3.575

7.  A procedure for quantitative determination of tris(2-carboxyethyl)phosphine, an odorless reducing agent more stable and effective than dithiothreitol.

Authors:  J C Han; G Y Han
Journal:  Anal Biochem       Date:  1994-07       Impact factor: 3.365

8.  Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.

Authors:  D S Wilbur; J E Stray; D K Hamlin; D K Curtis; R L Vessella
Journal:  Bioconjug Chem       Date:  1994 May-Jun       Impact factor: 4.774

9.  Thiopropyl-agarose as a solid phase reducing agent for chemical modification of IgG and F(ab')2.

Authors:  Natalia Ferraz; Juliana Leverrier; Francisco Batista-Viera; Carmen Manta
Journal:  Biotechnol Prog       Date:  2008 Sep-Oct

10.  Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

View more
  6 in total

1.  A novel differential scanning fluorimetry analysis of a humanized anti-cocaine mAb and its ligand binding characteristics.

Authors:  Terence L Kirley; Andrew B Norman; Hanna N Wetzel
Journal:  J Immunol Methods       Date:  2019-10-18       Impact factor: 2.303

2.  Unfolding of IgG domains detected by non-reducing SDS-PAGE.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  Biochem Biophys Res Commun       Date:  2018-06-23       Impact factor: 3.575

3.  Ligand binding to a humanized anti-cocaine mAb measured by dye absorption spectroscopy.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  Biochem Biophys Res Commun       Date:  2020-12-18       Impact factor: 3.575

4.  Domain unfolding of monoclonal antibody fragments revealed by non-reducing SDS-PAGE.

Authors:  Terence L Kirley; Kenneth D Greis; Andrew B Norman
Journal:  Biochem Biophys Rep       Date:  2018-10-31

Review 5.  Protein Engineering: Advances in Phage Display for Basic Science and Medical Research.

Authors:  Elena K Davydova
Journal:  Biochemistry (Mosc)       Date:  2022-01       Impact factor: 2.487

6.  Cocaine binding to the Fab fragment of a humanized anti-cocaine mAb quantitated by dye absorption and fluorescence spectroscopy.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  J Immunol Methods       Date:  2021-07-21       Impact factor: 2.287

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.